Premature ejaculation spray tested

A spray that helps men last five times longer when having sex may become the first treatment for premature ejaculation (PE) to be approved in the US.

The treatment, known as PSD502, is made from a combination of two sensation-numbing drugs. The 256 trial volunteers who suffer from PE lasted five times longer than when they were given a placebo, researchers said.

Lead scientist Professor Stanley Althof, from the Centre for Marital and Sexual Health of South Florida in West Palm Beach, US, explained: "PE can have a powerful negative impact on the emotional and sexual lives of men and their partners.

"Recently, the international sexual health community agreed that PE should be defined as ejaculation occurring within approximately one minute of penetration that causes the patient distress. Now we need to work to develop treatments, and these encouraging results with PSD502 seem to be a step in the right direction."

Copyright Press Association 2009

News articles provided by the Press Association for PruHealth. Whilst every care is taken to ensure accuracy of editorial content, PruHealth takes no responsibility for any errors or omissions. The views expressed in these articles are not necessarily those of PruHealth.